News

July 5, 2018July 5, 2018

Phase 1 Study of Potential Endometriosis Treatment, FOR-6219, Planned for UK

News

A Phase 1 clinical trial of a potential treatment for endometriosis, known as FOR-6219, is soon to begin in the U.K., after that country’s Medicines and Healthcare products Regulatory Agency (MHRA) granted permission for ... Read more

July 3, 2018July 3, 2018

Fatigue Is Common in Women with Endometriosis, but Research Hasn’t Kept Pace, Study Says

News

Women with endometriosis experience debilitating fatigue more than twice as often as those who don’t have the condition, yet fatigue isn’t discussed or researched widely enough in these patients, a recent ... Read more

June 28, 2018June 28, 2018

Endometriosis Not a Factor in Survival of Patients with Clear Cell Ovarian Cancer, Study Finds

News

Endometriosis does not worsen or improve survival of patients with ovarian clear cell carcinoma, a study suggests. Researchers found that for these patients, resistance to treatment with platinum-based chemotherapy is ... Read more

June 27, 2018June 27, 2018

Linzagolix Shows Potential to Reduce Endometriosis-Related Pain in Phase 2b Trial

News

Linzagolix can effectively reduce endometriosis-associated pain and improve patients’ health-related quality of life, according to preliminary data from the Phase 2b EDELWEISS clinical trial. Supported by these positive results, the ... Read more

June 26, 2018June 26, 2018

Red Meat Consumption Linked to Higher Risk of Endometriosis, Study Shows

News

Women who eat more red meat — especially of the non-processed variety — seem to be more likely to develop endometriosis, according to a prospective study. The study, “A prospective cohort ... Read more

June 20, 2018June 20, 2018

Updated ICER Report Questions Clinical Benefits, Cost-Effectiveness of Elagolix for Endometriosis

News

The Institute for Clinical and Economic Review (ICER) released an updated evidence report questioning the clinical benefits and value of elagolix (ABT-620), an investigational therapy being developed by AbbVie and Neurocrine Biosciences for endometriosis ... Read more

June 19, 2018June 19, 2018

Patients, Physicians Help Develop Questionnaire to Assess Painful Endometriosis Symptoms

News

Researchers developed a new questionnaire that accurately assesses painful experiences and can be used as a reliable tool in clinical trials and when diagnosing patients with endometriosis. Their study, “A ... Read more

June 13, 2018June 13, 2018

Obesity Linked to More Severe Endometriosis in Women, Study Finds

News

Obesity is linked to an increase in endometriosis severity and a reduced frequency of minimal stage disease, according to new research from Australia. The study was published in the Journal ... Read more

June 12, 2018June 12, 2018

Takeda Grants Aska Licensing Rights in Japan to Relugolix for Endometriosis, Uterine Fibroids

News

Takeda has granted commercialization rights to Aska Pharmaceuticals in Japan for the investigative therapy relugolix for the treatment of uterine fibroids, and development and commercialization rights for the treatment of endometriosis. Takeda has the ... Read more

June 12, 2018June 14, 2018

Chinese Clinical Trial to Assess Acupuncture Therapy for Pelvic Pain

endometriosis, News

A clinical trial will aim to determine the safety and effectiveness of acupuncture in relieving pelvic pain related to endometriosis. One-hundred-six participants who have been diagnosed with pelvic pain linked ... Read more